Cutaneous Manifestations of EGFR-Inhibitors in African Americans and Treatment Considerations

clonal inhibitor therapy in patients with metastatic colorectal cancer: a systematic review. Clin Colorectal Cancer 2018; 17(2): 85-96.
8. Alexis A, Lamb A. Concomitant therapy for acne in patients with skin of color: a case based approach. Dermatol Nurs 2009; 21(1): 33-36.
9. Lawson CN, et al. Updates in the understanding and treatments of skin and hair disorders in women of color. Int J Womens Dermatol 2017; S21-S37.
10. Karim NA, et al. Phase II clinical trial of gefitinib for the treatment of chemonaive patients with advanced non-small cell lung cancer with poor performance status. Clin Med Insights Oncol 2014; 8: 121-128.
11. Nijhawan RI, Alexis AF. Practical approaches to medical and cosmetic dermatology in skin of color patients. Expert Rev Dermatol 2011; 6(2): 175-187.
12. Davis EC, Callender VD. A review of acne in ethnic skin: pathogenesis, clinical manifestations, and management strategies. J Clin Aesthet Dermatol 2010; 3(4): 24-38.
13. Taylor SC. Skin of color: biology, structure, function, and implications for dermatologic disease. J Am Acad Dermatol 2002; 46(2): S41-S62.
14. Lang PG. Dermatoses in african americans. Dermatology Nursing 2000; 12(2): 87-100.
15. McMichael AJ. A review of cutaneous disease in african american patients. Dermatology Nursing 1999; 11(1): 35.